The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding
R. Rotolo, Vladimir Dragačević, Predrag Kalaba, E. Urban +14 more

